Jamadagni, S., Pandkar, P., Saundankar, T., Shirke, G., Malekar, S., & Vaidya, V. (2022). Efficacy of Madhav Rasayan Plus as adjuvant in moderate COVID-19 patients: Preliminary outcomes of randomized controlled trial. Elsevier.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्रJamadagni, Sameer, Prasad Pandkar, Tushar Saundankar, Girish Shirke, Shailesh Malekar, और V.G Vaidya. Efficacy of Madhav Rasayan Plus as Adjuvant in Moderate COVID-19 Patients: Preliminary Outcomes of Randomized Controlled Trial. Elsevier, 2022.
एमएलए (9वां संस्करण) प्रशस्ति पत्रJamadagni, Sameer, et al. Efficacy of Madhav Rasayan Plus as Adjuvant in Moderate COVID-19 Patients: Preliminary Outcomes of Randomized Controlled Trial. Elsevier, 2022.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.